Euro Commission launches study into counterfeiting and parallel trade
This article was originally published in Clinica
Executive Summary
The European Commission has told Clinica that there could be some tightening of the medical device regulatory framework to cope with the adverse effects of parallel trade. It has just launched a study that will focus on parallel trade at the same just as the study on combating counterfeit medical devices, anticipated at this time.